Repository logo
 
Publication

Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registry

dc.contributor.authorKotseva, K
dc.contributor.authorDe Backer, G
dc.contributor.authorDe Bacquer, D
dc.contributor.authorRydén, L
dc.contributor.authorHoes, A
dc.contributor.authorGrobbee, D
dc.contributor.authorMaggioni, A
dc.contributor.authorMarques-Vidal, P
dc.contributor.authorJennings, C
dc.contributor.authorAbreu, A
dc.contributor.authorAguiar, C
dc.contributor.authorBadariene, J
dc.contributor.authorBruthans, J
dc.contributor.authorCastro Conde, A
dc.contributor.authorCifkova, R
dc.contributor.authorCrowley, J
dc.contributor.authorDavletov, K
dc.contributor.authorDeckers, J
dc.contributor.authorDe Smedt, D
dc.contributor.authorDe Sutter, J
dc.contributor.authorDilic, M
dc.contributor.authorDolzhenko, M
dc.contributor.authorDzerve, V
dc.contributor.authorErglis, A
dc.contributor.authorFras, Z
dc.contributor.authorGaita, D
dc.contributor.authorGotcheva, N
dc.contributor.authorHeuschmann, P
dc.contributor.authorHasan-Ali, H
dc.contributor.authorJankowski, P
dc.contributor.authorLalic, N
dc.contributor.authorLehto, S
dc.contributor.authorLovic, D
dc.contributor.authorMancas, S
dc.contributor.authorMellbin, L
dc.contributor.authorMilicic, D
dc.contributor.authorMirrakhimov, E
dc.contributor.authorOganov, R
dc.contributor.authorPogosova, N
dc.contributor.authorReiner, Z
dc.contributor.authorStöerk, S
dc.contributor.authorTokgözoğlu, L
dc.contributor.authorTsioufis, C
dc.contributor.authorVulic, D
dc.contributor.authorWood, D
dc.date.accessioned2023-04-06T11:58:34Z
dc.date.available2023-04-06T11:58:34Z
dc.date.issued2019
dc.description.abstractAims: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results: A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. Conclusion: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationEur J Prev Cardiol . 2019;26(8):824-835.pt_PT
dc.identifier.doi10.1177/2047487318825350pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4474
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSagept_PT
dc.subjectHSM CARpt_PT
dc.subjectAgedpt_PT
dc.subjectFemalept_PT
dc.subjectMalept_PT
dc.subjectMiddle Agedpt_PT
dc.subjectHumanspt_PT
dc.subjectCardiovascular Agents / therapeutic use*pt_PT
dc.subjectCardiovascular Diseases / diagnosispt_PT
dc.subjectCardiovascular Diseases / epidemiologypt_PT
dc.subjectCardiovascular Diseases / physiopathologypt_PT
dc.subjectCardiovascular Diseases / prevention & control*pt_PT
dc.subjectCross-Sectional Studiespt_PT
dc.subjectDiet / adverse effectspt_PT
dc.subjectEurope / epidemiologypt_PT
dc.subjectHealth Care Surveyspt_PT
dc.subjectHealth Statuspt_PT
dc.subjectHealthy Lifestyle*pt_PT
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*pt_PT
dc.subjectLife Style*pt_PT
dc.subjectPatient Compliancept_PT
dc.subjectProtective Factorspt_PT
dc.subjectRegistriespt_PT
dc.subjectRisk Assessmentpt_PT
dc.subjectRisk Reduction Behavior*pt_PT
dc.subjectRisk Factorspt_PT
dc.subjectSecondary Preventionpt_PT
dc.subjectSedentary Behaviorpt_PT
dc.subjectSmoking / adverse effectspt_PT
dc.subjectSmoking / epidemiologypt_PT
dc.subjectTreatment Outcomept_PT
dc.titleLifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results From the European Society of Cardiology ESC-EORP EUROASPIRE V Registrypt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage835pt_PT
oaire.citation.issue8pt_PT
oaire.citation.startPage824pt_PT
oaire.citation.titleEuropean Journal of Preventive Cardiologypt_PT
oaire.citation.volume26pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Eur J Prev Cardiol 2019 824.pdf
Size:
410.33 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections